Azenta to Participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Azenta, Inc. (Nasdaq: AZTA) will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023, with a presentation starting at 4:30 pm ET.

Rhea-AI Summary

Azenta, Inc. (Nasdaq: AZTA) will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023, with a presentation starting at 4:30 pm ET. Investors can access the live webcast on the Azenta investor relations website and a replay will be available after the event. Azenta is a global leader in life sciences solutions, offering cold-chain sample management and genomic services for drug development and clinical research. Headquartered in Burlington, MA, the company operates across North America, Europe, and Asia.

Argus Session date unavailable

+0.10% session move Open Argus

Details

News Market Reaction – AZTA

The recorded move for AZTA in the trading session of this news was +0.10%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., March 15, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, which includes a presentation beginning at 4:30 pm ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com

Sherry Dinsmore
sherry.dinsmore@azenta.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-virtual-keybanc-capital-markets-life-sciences--medtech-investor-forum-301773479.html

SOURCE Azenta

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Azenta participating in the KeyBanc Capital Markets Investor Forum?

Azenta will participate on March 21, 2023.

What time is Azenta's presentation at the investor forum?

The presentation will begin at 4:30 pm ET.

How can I access the Azenta investor forum webcast?

The webcast can be accessed through the Azenta investor relations website.

What services does Azenta provide in the life sciences sector?

Azenta provides cold-chain sample management and genomic services for drug development and clinical research.

Where is Azenta located?

Azenta is headquartered in Burlington, Massachusetts.